Arkolith/Insider Trading/IMPL/Form 4

Parker H Stewart

DirectorIMPEL NEUROPHARMA INC (IMPL) · full profile →Form 4 · filed Apr 29, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
6 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 27, 2021Conversion(C)4K——4K
Apr 27, 2021Conversion(C)7K——11K
Apr 27, 2021Other(J)458—$011K
Apr 27, 2021Conversion(C)9K——19K
Apr 27, 2021Conversion(C)271$13.50$4K18K
Apr 27, 2021Other(J)2K—$018K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2021Conversion(C)61K—$00
Apr 27, 2021Option exercise(X)14K$8.19$113K0
Apr 27, 2021Option exercise(X)14K—$0120K
Apr 27, 2021Conversion(C)120K—$00
Apr 27, 2021Option exercise(X)47K$8.66$409K0
Apr 27, 2021Option exercise(X)47K—$0144K
Apr 27, 2021Conversion(C)144K—$00
Apr 27, 2021Conversion(C)0—$0—

Transaction Codes

C
Conversion of a derivative
J
Other acquisition / disposition
X
Exercise of in-the-money derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-029105) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML